CytexOrtho is a pre-clinical stage medical device company that is dedicated to advancing orthopaedic treatment options for cartilage repair. With a mission to leverage the groundbreaking tissue regeneration work of Dr. Farshid Guilak, Dr.

Bradley Estes, and Dr. Frank Moutos, CytexOrtho aims to revolutionize the field of orthopaedics. Led by Dr.

Guilak, the Executive Chairman of CytexOrtho and renowned researcher at Washington University in St. Louis, the company benefits from his expertise and guidance. Dr.

Estes, the CEO, and Dr. Moutos, the VP of Technology Development, also play key roles in driving the company's innovative initiatives. CytexOrtho's team is composed of exceptional individuals with diverse backgrounds and expertise in various areas of orthopaedics, including product development, research, and finance.

This skilled team strives to develop cutting-edge orthopaedic solutions that will transform the industry. Although their products are still in development and not yet FDA approved or commercially available, CytexOrtho's future technologies hold great promise. It's important to note that access to these innovations will depend on regulatory approval, and timelines may vary by country or region.

As a brand committed to advancing orthopaedic treatments, CytexOrtho is paving the way for a brighter future in cartilage repair